Characterization of myocardial oxidative metabolism and myocardial external efficiency in high-risk alcohol cardiotoxicity and alcoholic cardiomyopathy via dynamic 11 C-Acetate positron emission tomography

Ximin Shi,Shuai Liu,Xue Lin,Xihai Zhao,Ligang Fang,Jie Ding,Yonghong Dang,Haiqun Xing,Chunlei Han,Chengyan Dong,Bailing Hsu,Wei Fang,Fang Li,Li Huo,Juhani Knuuti
DOI: https://doi.org/10.1007/s12350-020-02214-0
2020-01-01
Journal of Nuclear Cardiology
Abstract:Introduction The purpose of this study was to evaluate subjects with high-risk alcohol cardiotoxicity and patients with alcoholic cardiomyopathy (ACM) via dynamic 11 C-Acetate positron emission tomography (PET) imaging as a myocardial oxidative metabolic probe. Methods and Results We recruited 37 subjects with chronic alcohol consumption [18 with moderate consumption (MC), 19 with heavy consumption (HC)], 5 ACM patients, and 12 healthy controls to receive dynamic 11 C-Acetate PET scans. PET imaging data were analyzed to calculate kinetic parameters (e.g., K mono , K 1 and k 2 ) based on the mono-exponential and one-tissue compartmental models. Myocardial oxygen consumption (MVO 2 ) and myocardial external efficiency (MEE) were then derived from these kinetic parameters. MVO 2 was significantly lowered in the HC group and in ACM patients (0.121± 0.018 and 0.111 ± 0.017 mL·g −1 ·min −1 , respectively) compared with those in healthy controls and MC subjects (0.144 ± 0.023 and 0.146 ± 0.027 mL·g −1 ·min −1 , respectively; P < .01). MEE was significantly reduced in ACM patients (13.0% ± 4.3%) compared with those of healthy controls (22.4% ± 4.6%, P < .01), MC subjects (20.1% ± 4.5%, P < .05), and HC subjects (22.3% ± 4.5%, P < .001). Conclusion Functional assessment via dynamic 11 C-Acetate PET imaging may represent a clinically feasible probe for identifying cohorts with high-risk cardiotoxicity due to addictive alcohol consumption and ACM.
What problem does this paper attempt to address?